Assessment of I-PRF Versus Nano MTA Combined with I-PRF Scaffold in Vital Pulp Therapy in Mature Mandibular First Molars
NCT ID: NCT06640205
Last Updated: 2024-10-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
51 participants
INTERVENTIONAL
2023-09-03
2025-09-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of L-PRF, Nanohydroxyapatite Combined With L-PRF Using Pulpotomy in Mature Mandibular First Molars
NCT06613932
Clinical and Radiographic Assessment of Nano-Bioactive Glass Combined With I-PRF Scaffold in Vital Pulp Treatments in Mandibular Molars With Closed Apices
NCT05876520
3Mixtatin and MTA Vital Pulpotomy in Primary Molars
NCT06478940
Evaluation of Nano Bioactive Glass Combined With i-PRF Scaffold in Vital Pulp Treatments
NCT05902936
Clinical and Radiographic Evaluation of Bioceramic Putty MTA Versus MTA in Pulpotomy of Immature Permanent Molars
NCT06219824
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MTA Pulpotomy
using MTA as pulpotomy capping agent in mature permanent teeth
pulpotomy
Removal of coronal pulp tissue and then placing pulpotomy agent
I-PRF pulpotomy
using I-PRF as pulpotomy capping agent in mature permanent teeth
pulpotomy
Removal of coronal pulp tissue and then placing pulpotomy agent
I-PRF combined with Nano MTA pulpotomy
using nano MTA mixed with I-prf as pulpotomy capping agent in mature permanent teeth
pulpotomy
Removal of coronal pulp tissue and then placing pulpotomy agent
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
pulpotomy
Removal of coronal pulp tissue and then placing pulpotomy agent
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients of either gender aged from 15-30.
* Tooth should give positive response to cold test.
* The tooth is restorable
* Patients should be free from any systemic disease that may affect normal healing and predictable outcome.
* Patients who will agree to the consent and will commit to follow-up period.
* Patients with mature root.
* Patients with no internal or external resorption and no periapical lesions.
* Soft tissues around the tooth are normal with no swelling or sinus tract.
Exclusion Criteria
* Haemostasias after 10 minutes can not be controlled after total pulpotomy
* Patients with periapical lesions or infections.
* Pregnant females.
* Patients with fistula or swelling
* Patients with necrotic pulp.
15 Years
30 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Future University in Egypt
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Abdelrahman Mohamed Elsayed Metwally Omar
Principle investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Abdelrahman Mo Omar, Master
Role: STUDY_CHAIR
Future University in Egypt
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Future university in egypt
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
(32)/8-2023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.